CellaVision AB Statistics
Total Valuation
CellaVision AB has a market cap or net worth of SEK 5.04 billion. The enterprise value is 4.94 billion.
Market Cap | 5.04B |
Enterprise Value | 4.94B |
Important Dates
The last earnings date was Thursday, October 24, 2024.
Earnings Date | Oct 24, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
CellaVision AB has 23.85 million shares outstanding. The number of shares has decreased by -75.00% in one year.
Current Share Class | n/a |
Shares Outstanding | 23.85M |
Shares Change (YoY) | -75.00% |
Shares Change (QoQ) | +400.00% |
Owned by Insiders (%) | 6.90% |
Owned by Institutions (%) | 60.77% |
Float | 19.81M |
Valuation Ratios
The trailing PE ratio is 33.58 and the forward PE ratio is 27.48. CellaVision AB's PEG ratio is 1.75.
PE Ratio | 33.58 |
Forward PE | 27.48 |
PS Ratio | 6.84 |
PB Ratio | 6.57 |
P/TBV Ratio | n/a |
P/FCF Ratio | 23.71 |
P/OCF Ratio | n/a |
PEG Ratio | 1.75 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 22.15, with an EV/FCF ratio of 23.23.
EV / Earnings | 32.90 |
EV / Sales | 6.70 |
EV / EBITDA | 22.15 |
EV / EBIT | 26.17 |
EV / FCF | 23.23 |
Financial Position
The company has a current ratio of 3.04, with a Debt / Equity ratio of 0.05.
Current Ratio | 3.04 |
Quick Ratio | 2.15 |
Debt / Equity | 0.05 |
Debt / EBITDA | 0.16 |
Debt / FCF | 0.17 |
Interest Coverage | 114.06 |
Financial Efficiency
Return on equity (ROE) is 20.78% and return on invested capital (ROIC) is 15.16%.
Return on Equity (ROE) | 20.78% |
Return on Assets (ROA) | 12.57% |
Return on Capital (ROIC) | 15.16% |
Revenue Per Employee | 3.23M |
Profits Per Employee | 658,829 |
Employee Count | 228 |
Asset Turnover | 0.78 |
Inventory Turnover | 1.91 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +32.78% in the last 52 weeks. The beta is 1.11, so CellaVision AB's price volatility has been higher than the market average.
Beta (5Y) | 1.11 |
52-Week Price Change | +32.78% |
50-Day Moving Average | 265.25 |
200-Day Moving Average | 252.47 |
Relative Strength Index (RSI) | 22.67 |
Average Volume (20 Days) | 27,554 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, CellaVision AB had revenue of SEK 737.16 million and earned 150.21 million in profits. Earnings per share was 6.30.
Revenue | 737.16M |
Gross Profit | 493.83M |
Operating Income | 188.88M |
Pretax Income | 188.74M |
Net Income | 150.21M |
EBITDA | 211.18M |
EBIT | 188.88M |
Earnings Per Share (EPS) | 6.30 |
Balance Sheet
The company has 137.66 million in cash and 35.39 million in debt, giving a net cash position of 102.28 million or 4.29 per share.
Cash & Cash Equivalents | 137.66M |
Total Debt | 35.39M |
Net Cash | 102.28M |
Net Cash Per Share | 4.29 |
Equity (Book Value) | 767.86M |
Book Value Per Share | 32.19 |
Working Capital | 264.16M |
Cash Flow
In the last 12 months, operating cash flow was 228.87 million and capital expenditures -16.09 million, giving a free cash flow of 212.77 million.
Operating Cash Flow | 228.87M |
Capital Expenditures | -16.09M |
Free Cash Flow | 212.77M |
FCF Per Share | 8.92 |
Margins
Gross margin is 66.99%, with operating and profit margins of 25.62% and 20.38%.
Gross Margin | 66.99% |
Operating Margin | 25.62% |
Pretax Margin | 25.60% |
Profit Margin | 20.38% |
EBITDA Margin | 28.65% |
EBIT Margin | 25.62% |
FCF Margin | 28.86% |
Dividends & Yields
This stock pays an annual dividend of 2.25, which amounts to a dividend yield of 1.06%.
Dividend Per Share | 2.25 |
Dividend Yield | 1.06% |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | 2 |
Payout Ratio | 35.73% |
Buyback Yield | 75.00% |
Shareholder Yield | 76.06% |
Earnings Yield | 2.98% |
FCF Yield | 4.22% |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | n/a |